(Sino-US HUGE REPORT) Informed that HUGE collagen had made a new breakthrough in application, Md. Fazlul Hoque , a merchant of HUGE collagen products in Bangladesh, the manager of R & D Department of the famous CLL Pharmaceutical Group, the master of Pharmacy had a study tour to HUGE to grab opportunities on March 22. Members of the R & D Department and International Trade Department of HUGE received him and organized a project meeting on the application of HUGE collagen in the field of diabetes.

 

The project meeting officially started at 2 p.m. that day. Firstly, Md. Fazlul Hoque showed his purpose of this visit: “As it is known to all, CLL is a large and mature pharmaceutical group, there are many products and drug stores belong to it, it has brought many products and technologis from developed countries, but seldom could cause such a big market reaction like HUGE collagen Ⅱproducts. The market share of collagen Ⅱproducts is increasing in Bangladesh, which rapidly improve the visibility of CLL in Bangladesh, collagen Ⅱproducts become the key products among the 600 medical products of CLL group. With 3 years’ friendly cooperation, we trust in HUGE collagen Ⅱproducts more and more. So when we noticed that your company has made a breakthrough in the field of diabetes, the Board of Directors and the senior leaders organized a meeting immediately and determined to appoint me to learn from you, hoping to grasp the technology of HUGE collagen Ⅱapplication in the field of curing diabetes soon and benefit the Bangladesh people.”

 

Members of our R & D Department introduced and showed new achievements of HUGE collagen Ⅱapplication in the field of diabetes. According to the introduction, these Innovative products solved the problems of the treatment limitations and side effects of the earlier drugs. This product is pure and natural biologically prepared, and the result indicated that it can bring the diabetes patients to the normal level in 3 to 4 months and have no adverse reactions and side effects by clinical test on 100 patients. This product is carrying on related examinations and approvals according to state regulations now.

 

Taking notes while listening to explanations during the introduction, Md. Fazlul Hoque held a thick conference note in one hand and HUGE collagen diabetes trial product in the other hand near the end of the meeting and said that: “There are many diabetes patients in Bangladesh, and the R & D Department of CLL company is facing great pressure, because diabetes is a worldwide problem, and we have been exploring and hoping for the breakthrough moments all the time. It is great that HUGE realized our dream! This is a worldwide breakthrough, I believe new collagen Ⅱdiabetes products will not only develop CLL group but also benefit Bangladesh people and people all around the world. Thank you for sharing the latest scientific research with us! Thank you very much!” 

 

Both sides agreed on economic cooperation on new collagen diabetes products in the end, and the project introduction ended in a circumstance of happiness and harmony.